Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Current Liabilities (2016 - 2025)

Surgery Partners' Total Current Liabilities history spans 12 years, with the latest figure at $615.5 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 1.43% year-over-year to $615.5 million; the TTM value through Dec 2025 reached $615.5 million, down 1.43%, while the annual FY2025 figure was $615.5 million, 1.43% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $615.5 million at Surgery Partners, up from $586.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $624.4 million in Q4 2024 and bottomed at $458.6 million in Q2 2023.
  • The 5-year median for Total Current Liabilities is $541.4 million (2021), against an average of $547.1 million.
  • The largest annual shift saw Total Current Liabilities soared 39.62% in 2021 before it decreased 19.69% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $536.8 million in 2021, then dropped by 8.08% to $493.4 million in 2022, then rose by 6.0% to $523.0 million in 2023, then increased by 19.39% to $624.4 million in 2024, then decreased by 1.43% to $615.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Total Current Liabilities are $615.5 million (Q4 2025), $586.0 million (Q3 2025), and $573.3 million (Q2 2025).